Peapack-Gladstone Financial Corporation (PGC)
NASDAQ: PGC · Real-Time Price · USD
27.14
+0.47 (1.76%)
Aug 13, 2025, 4:00 PM - Market closed
Achilles Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts that cover Achilles Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $37, which forecasts a 36.33% increase in the stock price over the next year. The lowest target is $35 and the highest is $39.
Price Target: $37 (+36.33%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Achilles Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Keefe, Bruyette & Woods | Keefe, Bruyette & Woods | Buy Maintains $38 → $35 | Buy | Maintains | $38 → $35 | +28.96% | Jul 23, 2025 |
| Keefe, Bruyette & Woods | Keefe, Bruyette & Woods | Buy Maintains $40 → $38 | Buy | Maintains | $40 → $38 | +40.01% | Apr 24, 2025 |
| Raymond James | Raymond James | Strong Buy Initiates $39 | Strong Buy | Initiates | $39 | +43.70% | Apr 11, 2025 |
| Keefe, Bruyette & Woods | Keefe, Bruyette & Woods | Buy Maintains $38 → $44 | Buy | Maintains | $38 → $44 | +62.12% | Dec 4, 2024 |
| Keefe, Bruyette & Woods | Keefe, Bruyette & Woods | Buy Reiterates $28 → $32 | Buy | Reiterates | $28 → $32 | +17.91% | Jul 29, 2024 |
Financial Forecast
Revenue This Year
284.22M
from 220.39M
Increased by 28.96%
Revenue Next Year
334.39M
from 284.22M
Increased by 17.65%
EPS This Year
2.58
from 1.85
Increased by 39.49%
EPS Next Year
3.91
from 2.58
Increased by 51.67%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 295.7M | 347.9M |
| Avg | 284.2M | 334.4M |
| Low | 275.5M | 324.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 34.2% | 22.4% |
| Avg | 29.0% | 17.7% |
| Low | 25.0% | 14.1% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | 2.88 | 4.42 |
| Avg | 2.58 | 3.91 |
| Low | 2.41 | 3.37 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | 55.5% | 71.3% |
| Avg | 39.5% | 51.7% |
| Low | 30.3% | 30.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.